Company registration number 06136694 (England and Wales)
CAPITAL INJECTION CERAMICS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
CAPITAL INJECTION CERAMICS LIMITED
COMPANY INFORMATION
Directors
Mr P P O'Brien
(Appointed 1 September 2025)
Mr D J Davidson
(Appointed 1 September 2025)
Mr R Keyzer-Dean
(Appointed 1 September 2025)
Secretary
Mr P P O'Brien
Company number
06136694
Registered office
C A Parsons Works
Shields Road
Newcastle Upon Tyne
NE6 2YL
Auditor
Sumer Auditco Limited
Albert Works
Sidney Street
Sheffield
S1 4RG
Bankers
Lloyds Bank
1 High Street
Sheffield
S1 2GA
CAPITAL INJECTION CERAMICS LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Balance sheet
8
Statement of changes in equity
9
Notes to the financial statements
10 - 21
CAPITAL INJECTION CERAMICS LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 1 -

The directors present the strategic report for the year ended 30 November 2025.

Review of the business

The principal activity of the company continued to be the manufacture and sale of injected ceramic cores for aerospace and industrial gas turbine applications. Demand remained strong throughout the financial year, supported by continued recovery in the global aerospace sector and sustained investment in industrial turbine technologies.

The company delivered a year of profitable growth, with a reported profit of £2.0m (2024: £1.8m) for the year ended 30 November 2025.

On 1 September 2025, Capital Injection Ceramics Limited was acquired by Siemens Energy Limited, marking a significant milestone in the company’s development. The acquisition provides greater strategic alignment with global turbine customers, strengthens our market position, and creates opportunities for accelerated investment, technology integration, and long‑term stability.

Growth and investment plans

Following the acquisition, the company has initiated a multi‑year programme focused on strengthening its operational capabilities and supporting long‑term growth. Key areas of focus include:

 

Principal risks and uncertainties

The company operates globally and therefore remains exposed to foreign currency fluctuations and international trade risks. The integration into Siemens Energy provides scale benefits that help mitigate these risks through global procurement and established hedging programmes.

Operational risks continue to be monitored closely, including energy prices, labour market conditions and materials availability. The directors are satisfied that appropriate controls and mitigation strategies are in place.

Key performance indicators

Key performance indicators monitored by the directors include:

Turnover - £15.5m (2024: £12.1m)

Operating profit - £2.9m (2024: £2.3m)

On-time delivery

Free cash flow

 

These metrics show continued improvement during the year, reflecting strong operational execution and sustained demand.

On behalf of the board

Mr D J Davidson
Director
9 June 2026
CAPITAL INJECTION CERAMICS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 2 -

The directors present their annual report and financial statements for the year ended 30 November 2025.

Principal activities

The principal activity of the company is that of the manufacture of ceramic cores and associated products used primarily in aerospace and industrial gas turbine manufacturing.

Results and dividends

The results for the year are set out on page 7.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

M L Stuart-Harris
(Resigned 1 September 2025)
J P R Newsome
(Resigned 1 September 2025)
S J Harris
(Resigned 1 September 2025)
Mr P P O'Brien
(Appointed 1 September 2025)
Mr D J Davidson
(Appointed 1 September 2025)
Mr R Keyzer-Dean
(Appointed 1 September 2025)
Research and development

The company engages in research and development activities with the main activities being process improvement.

Auditor

Sumer Auditco Limited were appointed as auditor to the company following BHP LLP becoming part of the Sumer Group on 31 December 2025, which required a change in audit firm to comply with applicable regulatory requirements. 

In accordance with section 487(2) of the Companies Act 2006, Sumer Auditco Limited are deemed to be reappointed annually.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

CAPITAL INJECTION CERAMICS LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 3 -
Strategic report

The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the company's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of future developments and financial instruments.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

On behalf of the board
Mr D J Davidson
Director
9 June 2026
CAPITAL INJECTION CERAMICS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CAPITAL INJECTION CERAMICS LIMITED
- 4 -
Opinion

We have audited the financial statements of Capital Injection Ceramics Limited (the 'company') for the year ended 30 November 2025 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

CAPITAL INJECTION CERAMICS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CAPITAL INJECTION CERAMICS LIMITED (CONTINUED)
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

 

CAPITAL INJECTION CERAMICS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CAPITAL INJECTION CERAMICS LIMITED (CONTINUED)
- 6 -

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

To address the risk of fraud through management bias and override of controls, we:

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

 

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Terri Pierpoint (Senior Statutory Auditor)
For and on behalf of Sumer Auditco Limited, Statutory Auditor
Chartered Accountants
Albert Works
Sidney Street
Sheffield
S1 4RG
10 June 2026
CAPITAL INJECTION CERAMICS LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 7 -
2025
2024
Notes
£
£
Turnover
3
15,481,765
12,114,299
Cost of sales
(8,529,457)
(6,903,810)
Gross profit
6,952,308
5,210,489
Administrative expenses
(4,062,696)
(2,887,398)
Operating profit
4
2,889,612
2,323,091
Interest receivable and similar income
7
68,150
66,982
Interest payable and similar expenses
8
-
0
(750)
Profit before taxation
2,957,762
2,389,323
Tax on profit
9
(971,495)
(618,079)
Profit for the financial year
1,986,267
1,771,244

The profit and loss account has been prepared on the basis that all operations are continuing operations.

CAPITAL INJECTION CERAMICS LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 8 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
11
133,690
151,320
Tangible assets
12
2,457,028
2,193,271
2,590,718
2,344,591
Current assets
Stocks
13
1,167,322
1,077,588
Debtors
14
4,519,422
3,751,959
Cash at bank and in hand
2,864,679
1,589,538
8,551,423
6,419,085
Creditors: amounts falling due within one year
15
(1,877,697)
(1,447,499)
Net current assets
6,673,726
4,971,586
Total assets less current liabilities
9,264,444
7,316,177
Provisions for liabilities
Deferred tax liability
16
578,000
616,000
(578,000)
(616,000)
Net assets
8,686,444
6,700,177
Capital and reserves
Called up share capital
18
20,000
20,000
Profit and loss reserves
8,666,444
6,680,177
Total equity
8,686,444
6,700,177

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 9 June 2026 and are signed on its behalf by:
Mr  R Keyzer-Dean
Director
Company registration number 06136694 (England and Wales)
CAPITAL INJECTION CERAMICS LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 9 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 December 2023
20,000
5,908,933
5,928,933
Year ended 30 November 2024:
Profit and total comprehensive income
-
1,771,244
1,771,244
Dividends
10
-
(1,000,000)
(1,000,000)
Balance at 30 November 2024
20,000
6,680,177
6,700,177
Year ended 30 November 2025:
Profit and total comprehensive income
-
1,986,267
1,986,267
Balance at 30 November 2025
20,000
8,666,444
8,686,444
CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 10 -
1
Accounting policies
Company information

Capital Injection Ceramics Limited is a private company limited by shares incorporated in England and Wales. The registered office is C A Parsons Works, Shields Road, Newcastle Upon Tyne, NE6 2YL.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Siemens Energy AG Group (ultimate parent undertaking). These consolidated financial statements are available to the public and can be obtained as set out in Note 23.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software
10 years
CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 11 -
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
20% reducing balance
Plant and machinery
20% reducing balance
Fixtures, fittings & equipment
15%  reducing balance
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 12 -
1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 13 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.15
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
2
Judgements and key sources of estimation uncertainty
(Continued)
- 14 -
Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Tangible assets

The charge in respect of depreciation is derived after determining an estimate of an asset’s expected useful life and the expected residual value at the end of its life. The useful lives and residual values of the company’s assets may vary depending on several factors such as, technological innovation, maintenance programmes and future market conditions. They are determined by management at the time the asset is acquired and reviewed annually for appropriateness.

3
Turnover and other revenue

An analysis of the company's turnover is as follows:

2025
2024
£
£
Turnover analysed by geographical market
UK
2,581,008
2,159,376
EC and Europe
4,882,003
4,367,258
Rest of the World
8,018,754
5,587,665
15,481,765
12,114,299
2025
2024
£
£
Other revenue
Interest income
68,150
66,982

No further geographical split of sales is presented as in the opinion of the directors this would be prejudicial to the interests of the entity.

4
Operating profit
2025
2024
Operating profit for the year is stated after charging:
£
£
Exchange losses
4,880
69,371
Fees payable to the company's auditor for the audit of the company's financial statements
14,613
13,750
Depreciation of tangible fixed assets
606,233
535,539
Amortisation of intangible assets
17,630
17,630
Operating lease charges
293,337
290,597
CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 15 -
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Production
78
74
Admin
5
5
Total
83
79

Their aggregate remuneration comprised:

2025
2024
£
£
Wages and salaries
3,834,999
2,331,890
Social security costs
465,179
207,270
Pension costs
109,152
156,206
4,409,330
2,695,366
6
Directors' remuneration

No remuneration was paid to the directors.

7
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
68,150
53,726
Other interest income
-
0
13,256
Total income
68,150
66,982
8
Interest payable and similar expenses
2025
2024
£
£
Other interest
-
0
750
CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 16 -
9
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
827,791
395,540
Adjustments in respect of prior periods
181,704
-
0
Total UK current tax
1,009,495
395,540
Foreign current tax on profits for the current period
-
0
1,539
Total current tax
1,009,495
397,079
Deferred tax
Origination and reversal of timing differences
(38,000)
221,000
Total tax charge
971,495
618,079

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
Profit before taxation
2,957,762
2,389,323
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
739,441
597,331
Tax effect of expenses that are not deductible in determining taxable profit
49,774
73
Adjustments in respect of prior years
181,704
-
0
Double tax relief
-
0
(874)
Permanent capital allowances in excess of depreciation
-
0
18,603
Foreign tax paid in the year
-
0
1,539
Deferred tax not recognised
(9)
1,407
Fixed asset differences
585
-
0
Taxation charge for the year
971,495
618,079
10
Dividends
2025
2024
£
£
Final paid
-
0
1,000,000
CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 17 -
11
Intangible fixed assets
Software
£
Cost
At 1 December 2024 and 30 November 2025
176,295
Amortisation and impairment
At 1 December 2024
24,975
Amortisation charged for the year
17,630
At 30 November 2025
42,605
Carrying amount
At 30 November 2025
133,690
At 30 November 2024
151,320
12
Tangible fixed assets
Leasehold improvements
Plant and machinery
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 December 2024
237,439
6,114,175
65,617
-
0
6,417,231
Additions
-
0
851,576
-
0
18,414
869,990
At 30 November 2025
237,439
6,965,751
65,617
18,414
7,287,221
Depreciation and impairment
At 1 December 2024
204,224
3,964,458
55,278
-
0
4,223,960
Depreciation charged in the year
6,643
595,737
1,551
2,302
606,233
At 30 November 2025
210,867
4,560,195
56,829
2,302
4,830,193
Carrying amount
At 30 November 2025
26,572
2,405,556
8,788
16,112
2,457,028
At 30 November 2024
33,215
2,149,717
10,339
-
0
2,193,271
13
Stocks
2025
2024
£
£
Raw materials and consumables
948,799
928,434
Work in progress
218,523
149,154
1,167,322
1,077,588
CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 18 -
14
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
3,191,836
2,952,166
Amounts owed by group undertakings
715,916
-
0
Other debtors
611,670
799,793
4,519,422
3,751,959
15
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
925,535
838,656
Amounts owed to group undertakings
-
0
17,387
Corporation tax
287,790
226,541
Other taxation and social security
139,214
57,970
Other creditors
11,076
11,051
Accruals and deferred income
514,082
295,894
1,877,697
1,447,499
16
Deferred taxation

Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
601,000
617,000
Short term timing differences
(23,000)
(1,000)
578,000
616,000
2025
Movements in the year:
£
Liability at 1 December 2024
616,000
Credit to profit or loss
(38,000)
Liability at 30 November 2025
578,000
CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 19 -
17
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
109,152
156,206

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

Accrued pension contributions at the year end in respect of defined contribution schemes amounted to £4,205 (2024: £4,368).

18
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
20,000
20,000
20,000
20,000
19
Financial commitments, guarantees and contingent liabilities

Subsequent to the reporting date, the Company received correspondence from its gas supplier in relation to alleged excess gas consumption above contractual thresholds for certain historical contract periods. The supplier has asserted that losses may have been incurred as a result of such excess usage and has indicated an intention to discuss a potential settlement.

 

At the reporting date, the Directors were not aware of any breach, claim, invoice or notification from the supplier in relation to this matter, nor had any correspondence or other information been received that would have reasonably led the Directors to conclude that a present obligation existed or that an outflow of economic benefits was probable.

 

The amount claimed by the supplier is dependent on pricing methodologies and system buy prices that were neither determinable nor reliably estimable by the Company at the reporting date. Furthermore, the matter remains disputed and subject to ongoing discussion with the supplier, and no invoice had been raised as at the date of approval of these financial statements.

 

Accordingly, no provision has been recognised in respect of this matter at the reporting date. At most, the Directors consider that this matter represents a contingent liability arising after the reporting period, the outcome and financial impact of which remain uncertain.

 

Based on information currently available, the Directors consider that any ultimate settlement, if payable, may be for an amount lower than that asserted; however, it is not practicable at this time to reliably estimate the timing or quantum of any potential outflow.

CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 20 -
20
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2025
2024
£
£
Within 1 year
282,214
242,902
Years 2-5
669,183
145,371
951,397
388,273
21
Capital commitments

Amounts contracted for but not provided in the financial statements:

2025
2024
£
£
Acquisition of tangible fixed assets
161,065
284,880
22
Related party transactions

On 1 September 2025, Siemens Energy Limited acquired 100% of the Company’s issued share capital.

Accordingly, Siemens Energy Limited became the Company’s immediate and ultimate parent undertaking and the ultimate controlling party.

As the wholly owned subsidiary of Siemens Energy Limited, the company has taken advantage of the exemption allowed with Section 33 of FRS 102 and has not disclosed transactions or balances with wholly owned subsidiary undertakings.

Capital Refractories Limited owned 75% of the share capital of Capital Injection Ceramics Limited up to 31 August 2025.

During the year, pre disposal, transactions with Capital Refractories Limited totalled £444,318 (2024: £609,107).

There were also transactions with Capital refractories Inc totalling £83,578 (2024: £99,647) and transactions with Capital Refractories SRO totalling £98,526 (2024: £72,933).

S J Harris owned 25% of the share capital of Capital Injection Ceramics Limited up to 31 August 2025.

Transactions with S J Harris during the year totalled £2,030 (2024: £nil).

S J Harris owns 50% of the share capital of Microtech Sales UK Ltd.

At the year end Microtech was no longer a related party. Transactions during the year up to the 31 August 2025 totalled £803,064 (2024: £1,087,317).

S J Harris also owns 35% of the share capital of KP Studio Limited.

At the year end KP was no longer a related party. Transactions during the year up to the 31 August 2025 totalled £62,837 (2024: £116,875).

 

CAPITAL INJECTION CERAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 21 -
23
Ultimate controlling party

The immediate parent company is Siemens Energy Limited, a company incorporated in England.

 

The ultimate parent undertaking is Siemens Energy AG, incorporated in Germany. Siemens Energy AG is the only Group undertakings of which the Company is a member for which Group financial statements are prepared. Copies of the Group financial statements are available on the internet at https://www.siemens-energy.com/global/en/company/investor-relations/publications-ad-hoc.html

 

or obtained from:

 

Siemens Energy AG

Otto-Hahn-Ring 6

D-81739 Munich

Germany

2025-11-302024-12-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100M L Stuart-HarrisJ P R NewsomeS J HarrisMr P P O'BrienMr D J DavidsonMr R Keyzer-DeanMr P P O'Brien061366942024-12-012025-11-3006136694bus:Director42024-12-012025-11-3006136694bus:Director52024-12-012025-11-3006136694bus:Director62024-12-012025-11-3006136694bus:CompanySecretary12024-12-012025-11-3006136694bus:Director12024-12-012025-11-3006136694bus:Director22024-12-012025-11-3006136694bus:Director32024-12-012025-11-3006136694bus:RegisteredOffice2024-12-012025-11-3006136694bus:Agent12024-12-012025-11-30061366942025-11-30061366942023-12-012024-11-3006136694core:RetainedEarningsAccumulatedLosses2023-12-012024-11-3006136694core:RetainedEarningsAccumulatedLosses2024-12-012025-11-3006136694core:IntangibleAssetsOtherThanGoodwill2025-11-3006136694core:IntangibleAssetsOtherThanGoodwill2024-11-3006136694core:ComputerSoftware2025-11-3006136694core:ComputerSoftware2024-11-30061366942024-11-3006136694core:LeasedAssetsHeldAsLessee2025-11-3006136694core:PlantMachinery2025-11-3006136694core:FurnitureFittings2025-11-3006136694core:MotorVehicles2025-11-3006136694core:LandBuildings2024-11-3006136694core:PlantMachinery2024-11-3006136694core:FurnitureFittings2024-11-3006136694core:MotorVehicles2024-11-3006136694core:CurrentFinancialInstrumentscore:WithinOneYear2025-11-3006136694core:CurrentFinancialInstrumentscore:WithinOneYear2024-11-3006136694core:ShareCapital2025-11-3006136694core:ShareCapital2024-11-3006136694core:RetainedEarningsAccumulatedLosses2025-11-3006136694core:RetainedEarningsAccumulatedLosses2024-11-3006136694core:ShareCapital2023-11-3006136694core:RetainedEarningsAccumulatedLosses2023-11-3006136694core:ShareCapitalOrdinaryShareClass12025-11-3006136694core:ShareCapitalOrdinaryShareClass12024-11-3006136694core:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-3006136694core:ComputerSoftware2024-12-012025-11-3006136694core:LandBuildingscore:LongLeaseholdAssets2024-12-012025-11-3006136694core:PlantMachinery2024-12-012025-11-3006136694core:FurnitureFittings2024-12-012025-11-3006136694core:MotorVehicles2024-12-012025-11-300613669412024-12-012025-11-300613669412023-12-012024-11-3006136694core:UKTax2024-12-012025-11-3006136694core:UKTax2023-12-012024-11-3006136694core:ForeignTax2024-12-012025-11-3006136694core:ForeignTax2023-12-012024-11-300613669422024-12-012025-11-300613669422023-12-012024-11-300613669432024-12-012025-11-300613669432023-12-012024-11-3006136694core:ComputerSoftware2024-11-3006136694core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-11-3006136694core:PlantMachinery2024-11-3006136694core:FurnitureFittings2024-11-3006136694core:MotorVehicles2024-11-30061366942024-11-3006136694core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-11-3006136694core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-12-012025-11-3006136694core:CurrentFinancialInstruments2025-11-3006136694core:CurrentFinancialInstruments2024-11-3006136694bus:OrdinaryShareClass12024-12-012025-11-3006136694bus:OrdinaryShareClass12025-11-3006136694bus:OrdinaryShareClass12024-11-3006136694core:WithinOneYear2025-11-3006136694core:WithinOneYear2024-11-3006136694core:BetweenTwoFiveYears2025-11-3006136694core:BetweenTwoFiveYears2024-11-3006136694bus:PrivateLimitedCompanyLtd2024-12-012025-11-3006136694bus:FRS1022024-12-012025-11-3006136694bus:Audited2024-12-012025-11-3006136694bus:FullAccounts2024-12-012025-11-30xbrli:purexbrli:sharesiso4217:GBP